Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.

The Long-read RNA-Seq Genome Annotation Assessment Project Consortium was formed to evaluate the effectiveness of long-read approaches for transcriptome analysis. Using different protocols and sequencing platforms, the consortium generated over 427 million long-read sequences from complementary DNA and direct RNA datasets, encompassing human, mouse and manatee species. Developers utilized these data to address challenges in transcript isoform detection, quantification and de novo transcript detection. The study revealed that libraries with longer, more accurate sequences produce more accurate transcripts than those with increased read depth, whereas greater read depth improved quantification accuracy. In well-annotated genomes, tools based on reference sequences demonstrated the best performance. Incorporating additional orthogonal data and replicate samples is advised when aiming to detect rare and novel transcripts or using reference-free approaches. This collaborative study offers a benchmark for current practices and provides direction for future method development in transcriptome analysis.

The impact of time from ILD diagnosis to referral to the transplant center on the probability of inclusion in the transplant waiting list.

BACKGROUND: Lung transplant is a therapeutic option for patients with progressive interstitial lung disease (ILD). OBJECTIVES: The objective of this study was to determine whether time from ILD diagnosis to referral to a transplant center influences the probability of being included in the transplant waiting list. METHODS: We performed a retrospective cohort study including all ILD patients evaluated as lung transplantation (LT) candidates at a lung transplant center between 01/01/2017 and 31/12/2022. The primary endpoint was the probability of being included in the lung transplant waiting list according to the time elapsed from diagnosis to referral to the transplant center. RESULTS: A total of 843 lung transplant requests were received, of which 367 (43.5%) were associated with ILD. Thirteen patients were excluded because they did not attend the first visit, whereas another 11 were excluded because some information was missing. As a result, our final sample was composed of 343 patients. The median time from diagnosis to referral was 29.4 (10.9 - 61.1) months. The overall probability of inclusion in the waiting list was 29.7%. By time from diagnosis to referral, the probability of inclusion in the waiting list was 48.1% for the patients referred 〈 6 months from diagnosis; 27.5% for patients referred 6 to 24 months from diagnosis; and 25.8% for patients referred 〉 24 months from diagnosis (p = 0.007). CONCLUSIONS: Early referral to a lung transplant center seemed to increase the probability of being included in the lung transplant waiting list. Further research is needed in this topic.

Osteopontin as a Biomarker in Interstitial Lung Diseases.

Osteopontin (OPN) is a glycoprotein involved in Th1 and Th17 differentiation, and inflammation and tissue remodeling. OPN is a biomarker of disease activity in patients with autoimmune inflammatory conditions. This study aimed to assess the diagnostic and prognostic value of OPN in interstitial lung diseases (ILDs). Between May 2016 and October 2019, 344 patients with ILD were recruited at the Hospital Universitario Marqués de Valdecilla (Spain) and were prospectively followed-up. This study involved the determination of OPN serum levels by ELISA and OPN RNA expression quantified using qPCR. Six genetic polymorphisms in OPN (rs28357094, rs2853749, rs2853750, rs11728697, rs7695531, and rs1126616) were genotyped using TaqMan assays. OPN serum levels were also assessed in 140 healthy controls. OPN serum levels (median [interquartile range]) were significantly higher in ILD patients than in controls (1.05 [0.75-1.51] ng/mL versus 0.81 [0.65-0.98] ng/mL in healthy controls; p < 0.01). OPN serum levels were inversely correlated with the forced vital capacity. OPN serum levels were also higher in ILD patients who died or underwent lung transplantation when compared with the remaining ILD patients (1.15 [0.80-1.72] ng/mL versus 0.99 [0.66-1.32] ng/mL; p = 0.05). Survival worsened in ILD patients with OPN > 1.03 ng/mL at 1, 3, and 5 years. No statistically significant differences in the genetic frequencies of OPN polymorphisms or the RNA expression were found among the different ILD groups. Elevated levels of OPN in the serum may be a useful indicator in identifying patients with ILD who are more likely to experience poor outcomes.

Acetonitrile real gas phase behavior from quasi-ideal gas to nanodroplets: A microscopical view.

We have applied a recently developed general purpose acetonitrile force field based on first-principles calculations to simulate acetonitrile in the gas phase at different temperatures and densities. These conditions range from nearly ideal to real gas phase behavior and condensation. The molecular dynamics simulation results agree fairly well with the experimental studies available in the literature on the gas samples. The structural analysis of aggregates and their associated interaction energies is examined and related to the early model proposed on molecular association and equilibrium determining the non-ideal behavior. The formation of dimers is mainly responsible for the non-ideal behavior of the gas at very low density, confirming suggested models based on previous experimental studies. However, when the density of the sample rises, the level of aggregation increases and the simple concept of dimerization does not hold anymore. The real behavior adopted by the gas is related to the distribution of molecular structures observed. The macroscopical view of a real gas as a generic interparticle interaction system without a defined form may then be rationalized on the basis of a defined molecular association originated by a distribution of aggregates at the low density regime. The sample with the highest density (∼1.4 × 103 mol m-3) at the lowest temperature exhibits a massive aggregation where most of the acetonitrile (ACN) molecules in the simulation box form a big cluster. Its radial distribution function is similar to that of the liquid ACN. This strongly inhomogeneous distribution in the box can be considered a condensation in the gas phase under specific density-T conditions. This formation opens the door to the potential tuning of its solvent properties as a function of its size in these nanodroplets that in turn are controlled by the density-T conditions.

Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.

BACKGROUND: Chemotherapy, the mainstay treatment for metastatic cancer, presents serious side effects due to off-target exposure. In addition to the negative impact on patients' quality of life, side effects limit the dose that can be administered and thus the efficacy of the drug. Encapsulation of chemotherapeutic drugs in nanocarriers is a promising strategy to mitigate these issues. However, avoiding premature drug release from the nanocarriers and selectively targeting the tumour remains a challenge. RESULTS: In this study, we present a pioneering method for drug integration into nanoparticles known as mesoporous organosilica drugs (MODs), a distinctive variant of periodic mesoporous organosilica nanoparticles (PMOs) in which the drug is an inherent component of the silica nanoparticle structure. This groundbreaking approach involves the chemical modification of drugs to produce bis-organosilane prodrugs, which act as silica precursors for MOD synthesis. Mitoxantrone (MTO), a drug used to treat metastatic breast cancer, was selected for the development of MTO@MOD nanomedicines, which demonstrated a significant reduction in breast cancer cell viability. Several MODs with different amounts of MTO were synthesised and found to be efficient nanoplatforms for the sustained delivery of MTO after biodegradation. In addition, Fe3O4 NPs were incorporated into the MODs to generate magnetic MODs to actively target the tumour and further enhance drug efficacy. Importantly, magnetic MTO@MODs underwent a Fenton reaction, which increased cancer cell death twofold compared to non-magnetic MODs. CONCLUSIONS: A new PMO-based material, MOD nanomedicines, was synthesised using the chemotherapeutic drug MTO as a silica precursor. MTO@MOD nanomedicines demonstrated their efficacy in significantly reducing the viability of breast cancer cells. In addition, we incorporated Fe3O4 into MODs to generate magnetic MODs for active tumour targeting and enhanced drug efficacy by ROS generation. These findings pave the way for the designing of silica-based multitherapeutic nanomedicines for cancer treatment with improved drug delivery, reduced side effects and enhanced efficacy.

Association of Acidotolerant Cyanobacteria to Microbial Mats below pH 1 in Acidic Mineral Precipitates in Río Tinto River in Spain.

This report describes acidic microbial mats containing cyanobacteria that are strongly associated to precipitated minerals in the source area of Río Tinto. Río Tinto (Huelva, Southwestern Spain) is an extreme acidic environment where iron and sulfur cycles play a fundamental role in sustaining the extremely low pH and the high concentration of heavy metals, while maintaining a high level of microbial diversity. These multi-layered mineral deposits are stable all year round and are characterized by a succession of thick greenish-blue and brownish layers mainly composed of natrojarosite. The temperature and absorbance above and below the mineral precipitates were followed and stable conditions were detected inside the mineral precipitates. Different methodologies, scanning and transmission electron microscopy, immunological detection, fluorescence in situ hybridization, and metagenomic analysis were used to describe the biodiversity existing in these microbial mats, demonstrating, for the first time, the existence of acid-tolerant cyanobacteria in a hyperacidic environment of below pH 1. Up to 0.46% of the classified sequences belong to cyanobacterial microorganisms, and 1.47% of the aligned DNA reads belong to the Cyanobacteria clade.

Draft genome sequence of the deep-subsurface Ciceribacter sp. strain T2.26MG-112.2, a second Rhizobiaceae isolated from the Iberian Pyrite Belt at 492.6 mbs.

T2.26MG-112.2 is a Ciceribacter strain that has been isolated from the deep subsurface of the Iberian Pyrite Belt. We report its draft genome consisting of a chromosome of ≈4.9 Mb and a plasmid of 357 kb. The annotation reveals 4,824 coding sequences, 48 tRNA genes, and 1 rRNA operon.

Evaluating Sensitization-associated, Neuropathic-like Symptoms and Psychological Factors in Patients With Interstitial Lung Disease.

The aims of this study were to phenotype pain in patients with interstitial lung disease (ILD) by investigating the association between sensitization-associated symptoms with quality of life, anxiety/depression, pain catastrophizing, and kinesiophobia levels and identifying those risk factors explaining the variance of quality of life in individuals with ILD and pain. One hundred and thirty-two (38.6% women, mean age: 70, standard deviation: 10.5 years) patients with ILD completed clinical (age, sex, height, weight), psychological (Hospital Anxiety and Depression Scale [HADS] and the Pittsburgh Sleep Quality Index), and health-related quality of life (EQ-5D-5L) variables, as well as the Central Sensitization Inventory (CSI), the Self-Report Leeds Assessment of Neuropathic Symptoms (S-LANSS), Pain Catastrophizing Scale, and Tampa Scale for Kinesiophobia (TSK-11) questionnaires. The prevalence of sensitization-associated symptomatology (CSI), neuropathic-like features (S-LANSS), anxiety symptoms, depressive symptoms, or poor sleep was 20.5%, 23.5%, 23.6%, 22.9%, or 51.6%. Significant associations between CSI, S-LANSS, HADS-A, HADS-D, Pain Catastrophizing Scale, TSK-11, and EQ-5D-5L (.220 < r < .716) were found. The regression analysis revealed that CSI, TSK-11, and HADS-D explained 44.8% of the variance of EQ-5D-5L (r2 adjusted: .448). This study found the presence of sensitization-associated and neuropathic-like symptoms as well as other central nervous system-derived symptoms, such as anxiety, depression, poor sleep, pain catastrophizing, and kinesiophobia in 25% of ILD patients with pain. Sensitization-associated symptoms, depression, and kinesiophobia were associated with a worse quality of life. These findings would support that individuals with ILD can exhibit different pain phenotypes, including nociplastic-like pain phenotype based on self-reported measurements. PERSPECTIVE: Pain in patients with ILD can fulfill features of different phenotypes, including nociplastic pain, when sensory, emotional, and cognitive mechanisms are involved at the same time.

Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients.

BACKGROUND & AIM: Pulmonary hypertension (PH) secondary to lung disease (Group-3 PH) is the second leading cause of PH. The role of PH as a risk factor for primary graft dysfunction (PGD) following lung transplant (LT) is controversial. OBJECTIVE: To assess the impact that the new definition of PH had on the prevalence of PH in patients with advanced lung disease-candidate for LT, and its association with the occurrence of PGD. METHOD: A retrospective study was performed in all patients undergoing cardiac catheterisation referred for consideration as candidates to LT in a centre between 1 January 2017 and 31 December 2022. The baseline and haemodynamic characteristics of patients were analysed, along with the occurrence of PGD and post-transplant course in those who ultimately underwent transplantation. RESULTS: A total of 396 patients were included. Based on the new 2022 European Society of Cardiology/European Respiratory Society definitions, as many as 70.7% of patients met PH criteria. Since the introduction of the 2022 definition, a significant reduction was observed in the frequency of severe Group-3 PH (41.1% vs 10.3%; p<0.001), with respect to the 2015 definition. As many as 236 patients underwent transplantation. None of the variables associated with PH was identified as a risk factor for PGD. CONCLUSION: The new classification did not have any impact on the prevalence of PGD after transplantation. These results exclude that any significant differences exist in the baseline characteristics or post-transplant course of patients with Group-3 PH vs unclassified PH.

Detectando caras en un contexto de sorpresa e incertidumbre / Detecting facial expressions within a context of surprise and uncertainty

Las expresiones de amenaza son detectadas con rapidez y precisión, advirtiendo a quienes las observan de la presencia de un potencial peligro. Durante el proceso de detección, la expresión de sorpresa podría jugar un papel importante como clave de orientación en condiciones de incertidumbre donde se requiere una respuesta rápida y precisa. Con el objetivo de analizar este supuesto se plateó un experimento en el que participaron 70 sujetos que realizaron una tarea de señalización espacial, donde se utilizaron expresiones faciales de sorpresa (vs. neutra) como claves de orientación, y expresiones faciales de miedo, ira, alegría y neutras como estímulos objetivo. Los resultados mostraron un efecto facilitador de la expresión de sorpresa solo en la detección de la expresión de ira, reduciendo los tiempos de respuesta y el porcentaje de errores. Los datos apuntan a que la expresión de sorpresa, cuando se procesa como un estímulo independiente, podría facilitar la detección de aquellos estímulos que supongan una amenaza directa, como la expresión de ira, siendo esta distinción clave para entender en qué condiciones se detecta más eficazmente la expresión de ira respecto a otro tipo de expresiones.(AU)

Threatening expressions are detected quickly and accurately, warning the observer of the presence of a potential danger. During the de-tection process, a facial expression of surprise could play an important role as a cue for orientation in conditions of uncertainty that call for a swift and precise response. With a view to analysing this contingency, an experiment was conducted in which 70 subjects undertook a spatial cueing task that involved facial expressions of surprise (vs. neutral ones) as orientation cues, and facial expressions of fear, anger and happiness as target stimuli. The results revealed a priming effect of the expression of surprise solely in the detection of the expression of anger, reducing response times and the percentage of errors. Thedata indicate that the expression of surprise, when processed as an independent stimulus, could prime the detection of those stimuli that constitute a direct threat, such as the expression of anger, with this being a crucial distinction for understanding the circumstances in which the expression of anger is detected more effectively than other kinds of expressions.(AU)

Índice trabecular óseo y niveles de 25-hidroxivitamina D en las complicaciones microvasculares de la diabetes mellitus tipo 2 / Trabecular bone score and 25-hydroxyvitamin D levels in microvascular complications of type 2 diabetes mellitus

Antecedentes y objetivo:La enfermedad microvascular (EMV) diabética ha sido asociada con una fragilidad ósea incrementada. El objetivo fue analizar la relación entre la EMV y la microestructura trabecular -evaluada mediante el índice trabecular óseo (trabecular bone score, TBS)- en pacientes diabéticos tipo 2 (DM2). Adicionalmente, conocer la relación entre la vitamina D y la EMV.Pacientes y métodos:Diseño transversal analítico, que incluyó varones > 50 años y mujeres postmenopáusicas con DM2, participantes en una cohorte poblacional. Se clasificó como EMV+ la presencia de nefropatía, neuropatía y/o retinopatía. Fueron analizadas variables clínicas, de laboratorio, el TBS, la 25-hidroxivitamina D [25(OH)D] y la densidad mineral ósea (DMO). Se realizaron análisis bivariable y multivariable.Resultados:Fueron evaluados 361 pacientes (51,1% mujeres), de 63,8 (9) años. De ellos, 92 tenían EMV, con un peor control metabólico, mayor duración de la DM2, menor TBS (1,235 [0,1] vs. 1,287 [0,1]; p=0,003) y menores niveles de 25(OH)D (18,3 [7] vs. 21,6 [8] ng/mL; p=0,0001). No hubo diferencias entre EMV+ y EMV- en la DMO ni en los marcadores P1NP y β-CTX. Tras ajustar por confusores, incluyendo HbA1c y duración de la DM2, el TBS en EMV+ fue 1,252 (IC 95% 1,230-1,274) vs. 1,281 (IC 95% 1,267-1,295) en EMV- (p=0,034). La EMV se asoció a un nivel de 25(OH)D < 20 ng/mL con una OR ajustada=1,88 (IC 95% 1,06-3,31; p=0,028).Conclusiones:Los pacientes con EMV presentaron un TBS significativamente menor, tras ajustar por confusores. El análisis multivariable mostró asimismo una asociación significativa entre un nivel bajo de 25(OH)D y la EMV prevalente. (AU)

Background and objective:Diabetic microvascular disease (MVD) has been associated with increased bone fragility. The objective was to analyse the relationship between MVD and trabecular microstructure -assessed by the trabecular bone score (TBS)- in type 2 diabetic (T2D) patients. A second aim was to know the relationship between vitamin D and MVD.Patients and methods:Cross-sectional study, which included men >50 years and postmenopausal women participating in a population-based cohort, diagnosed with T2D. The presence of nephropathy, neuropathy and/or retinopathy was classified as MVD+. Clinical and laboratory variables, TBS, 25(OH)D and BMD by DXA, were evaluated. Bivariate and multivariate analysis were performed.Results:We evaluated 361 patients (51.1% women), 63.8 (9) years old. Of them, 92 were MVD+ and presented poorer metabolic control, longer duration of T2D, lower TBS [1.235 (.1) vs. 1.287 (.1); p=.007] and lower levels of 25(OH)D [18.3 (7) vs. 21.6 (8) ng/ml; p=.0001). There were no differences between MVD+ and MVD- with regard to BMD or P1NP and β-CTX markers. After adjusting for confounders, including HbA1c and duration of T2D, the TBS value in MVD+ was 1.252 (95% CI 1.230-1.274) vs. 1.281 (95% CI 1.267-1.295) in MVD- (p=.034). MVD was associated with a 25(OH)D level <20 ng ml with an adjusted OR of 1.88 (95% CI 1.06-3.31; p=.028).Conclusions:The MVD+ patients presented a significantly lower TBS, after adjusting for confounders. Furthermore, multivariable analysis showed a significant relationship between a low 25(OH)D level and a prevalent MVD. (AU)

Sequential priming in the detection of the facial expression: new approach in the study of emotional detection

The effective detection of those facial expressions that alert us to a possible threat is adaptive. Hence the reason that studies on face sampling have involved analysing how this process occurs, with evidence to show that the eyes focus mainly on the upper side of the face; nevertheless, no clear determination has been made of the relationship between the efficacy in detection (speed and accuracy) and the way in which emotions are visually tracked on the face. A sequential priming task was therefore held in which the four quadrants of the face were displayed consecutively, for 50 ms each one, and in a different order (24 sequences). The results reveal a quicker response when the priming sequence begins in the upper part, continues downward to the right-hand side of the face, and then follows an anti-clockwise direction. The results are discussed in the light of studies using the Eye-Tracking technique

La eficacia en ladetección de las expresiones faciales que nos alertan deuna posible amenaza es adaptativa. Por esta razón, los estudios sobre rastreo facial se han interesado en el análisis de este proceso, encontrándose evidenciasde quela miradase enfoca prioritariamente a la parte superior del rostro; sin embargo, no se ha establecido de manera clara la relación entre la eficacia en la detección (velocidad y precisión)y la forma en la que se rastrean las expresiones faciales emocionales. Con el objetivo de aportarclaridad en este punto, se realizó una tarea de priming secuencial en la que se mostraban los cuatro cuadrantes de la cara de manera consecutiva, durante 50 ms cada uno, y en un orden diferente (24 secuencias). Los resultados mostraron una respuesta más rápida cuando las secuencias de priming comenzaban en la parte superior, continuabanhacia abajo en el lado derecho, y posteriormente seguían la dirección contraria a la agujas del reloj. Se discuten losresultados a la luz de los estudios que utilizan la técnica de Eye-Tracking

Prevalencia de sobrepeso y obesidad en niños escolares / Prevalence of overweight and obesity in school-age children

Resumen Introducción: La obesidad infantil es un reto de salud pública. Entre 1999 y 2012, en México la prevalencia de sobrepeso y obesidad (SO) en niños escolares pasó de 25.5 a 32 %. Objetivo: Reportar la prevalencia actual de SO en niños escolares del municipio de Durango, México. Método: Encuesta transversal realizada entre enero de 2017 y diciembre de 2018. Se incluyeron 24 600 niños de seis a 11 años, de 138 escuelas del municipio de Durango. Se utilizaron los valores de referencia del índice de masa corporal establecidos por la Organización Mundial de la Salud para determinar la presencia de SO. Resultados: La prevalencia de sobrepeso fue de 19.7 %, la de obesidad de 16 % y la de SO de 35.7 %. En el grupo de seis años se encontró una prevalencia de SO de 25.4 % y en el de 11 años, de 41.1 %. Conclusiones: La prevalencia de SO en niños de seis a 11 años del municipio de Durango es más elevada que la reportada en la encuesta nacional por entidad federativa en 2012 y la nacional en 2016; se observó tendencia al incremento conforme aumenta la edad.

Abstract Introduction: Childhood obesity is a public health challenge. Between 1999 and 2012, the prevalence in Mexico of overweight and obesity in schoolchildren went from 25.5 to 32 %. Objective: To report current prevalence of overweight and obesity in schoolchildren from the municipality of Durango, Mexico. Method: Cross-sectional survey conducted between January 2017 and December 2018. A total of 24,600 children aged between six and 11 years from 138 schools of the municipality of Durango were included. The body mass index reference values established by the World Health Organization were used to determine the presence of overweight and obesity. Results: The prevalence of overweight was 19.7 %, of obesity, 16 %, and of overweight and obesity combined, 35.7 %. In the six-year-old group, a prevalence of overweight-obesity of 25.4 % was found, and in the 11-year-old group, 41.1 %. Conclusions: The prevalence of overweight-obesity in children aged from 6 to 11 years in the municipality of Durango is higher than those reported in the national survey by states in 2012 and in the 2016 national survey; prevalence showed a tendency to increase with age.

Genética a gusto del consumidor: una práctica que no encaja en nuestro Derecho / No disponible

Los test genéticos directos al consumidor tienen por objeto conocer la predisposición a padecer enfermedades comunes de origen multifactorial. Tal y como se ofrecen constituyen un reclamo cuya calidad y utilidad no ha sido probada, ya que, en muchos casos, no predicen el desarrollo de la enfermedad ni su gravedad. Objeciones tales como la falta de información y de consejo genético, el impacto en el individuo y en su familia, la agresiva publicidad y el riesgo de estigmatización justifican la adopción de cautelas y el sometimiento a unos estrictos estándares éticos y jurídicos

Direct-to-consumer genetic testing aim to meet the predisposition to common diseases of multifactorial origin. These tests are offered as a form of claim whose quality and usefulness has not been tested, since in many cases do not predict the development of the disease or its severity. Objections such as lack of information and genetic counselling, the impact on the individual and his family, aggressive advertising and the risk of stigmatization justify the need to take precautionary measures and to be subject to strict ethical and legal standards

Bulla pulmonar gigante sobreinfectada / Giant Pulmonary Bulla Superinfection

No disponible

Efecto protector de los análogos de la GnRH sobre la capacidad reproductiva de las mujeres en edad fértil con neoplasia o enfermedad autoinmunitaria tratadas con fármacos citotóxicos. Resultado final de un ensayo clínico fase II / Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial

Fundamento y objetivo: Para evitar el efecto tóxico quimioterápico se ha propuesto la utilización de análogos agonistas de la GnRH (aGnRH) para inhibir la depleción de folículos ováricos. Existen controversias sobre su eficacia, por lo que se ha realizado un ensayo clínico para valorar el efecto protector de los análogos de la GnRH en mujeres afectadas de cáncer y enfermedades autoinmunitarias tratadas con fármacos citotóxicos. Pacientes y métodos: Ensayo clínico, de fase ii, unicéntrico y abierto. Durante el tratamiento quimioterápico se administraron 5 dosis de análogo antagonista de la GnRH en intervalos de 3 días y/o una dosis mensual de aGnRH. Se realizaron determinaciones hormonales previamente al inicio del tratamiento quimioterápico y al finalizar este. Resultados: La inclusión de las pacientes se concluyó precozmente al introducir como parámetro de evaluación de la reserva ovárica la determinación de hormona antimulleriana (HAM). De las 38 pacientes seguidas, 23 (60,5%, IC95% 43,4-76,0) presentaron valores de AMH por debajo de la normalidad tras la conclusión del tratamiento. Se realizó un análisis intermedio en el que se observó que el 86,6% (IC95% 71,9-95,6) de las pacientes recuperaban el ciclo menstrual, pero estas presentaban una reducción de los niveles de HAM. Conclusión: Aunque la mayoría de las pacientes presentaron recuperación de los ciclos menstruales, la reserva ovárica disminuyó en la mayoría de ellas, por lo que podemos concluir que la administración concomitante al tratamiento quimioterápico de análogos de la GnRH no preserva de la pérdida de la población folicular ovárica (AU)

Background and objective: In order to avoid the toxic effect of chemotherapy, it has been proposed to use GnRH agonist analogues (GnRHa) to inhibit the depletion of ovarian follicles. Nevertheless, there is controversy about its effectiveness. This clinical trial has been conducted with the aim to assess the protective effect of GnRH analogues on the reproductive capacity of women with malignancies or autoimmune diseases, which require chemotherapy. Patients and methods: Open phase ii single-center clinical trial. During chemotherapy, a total of 5 doses of GnRH antagonist analogue at a dose interval of 3 days and/or a monthly dose of GnRHa were administered. Hormonal determinations prior to the start of the CT treatment were conducted during treatment and at the end of it. Results: The inclusion of patients was prematurely concluded when incorporating the determination of anti-Müllerian hormone (AMH) as a parameter for assessing the ovarian reserve. Out of 38 patients, 23 (60.5%, 95%CI 43.4-76.0) had AMH values below normal following completion of treatment. An intermediate analysis was carried out observing that while most patients were recovering the menstrual cycle (86.6% 95%CI 71.9-95.6), they had reduced levels of AMH. Conclusion: Although most patients recovered their menstrual cycles, the ovarian reserve, assessed by the concentration of AMH, decreased in many patients. Therefore, we can conclude that the concomitant treatment of chemotherapy and GnRH analogues does not preserve the loss of follicular ovarian reserve (AU)

Incapacidad y aptitud laboral. Nuevas sinergias entre medicina evaluadora y medicina laboral. Historia clínica laboral única: la capacidad laboral, un continuo evolutivo / No disponible

En España coexisten dos sistemas públicos de salud: el universal, gestionado por las comunidades autónomas y financiado con impuestos, y el laboral, gestionado por las Mutuas y financiado por cuotas a la Seguridad Social, los cuales se reparten la responsabilidad de gestión de la incapacidad laboral. Esta doble dependencia dificulta la gestión de esta importante prestación sanitaria y social. Una gestión que es diferente en función de la etiología (común o profesional) y su pronóstico (temporal o permanente). Para poder comprender mejor la naturaleza de la incapacidad laboral, y que su investigación sea útil para mejorar su gestión médica y social, conviene adoptar una perspectiva longitudinal (life course research), analizando trayectorias de incapacidad en los individuos, y no solo episodios aislados. Una trayectoria de incapacidad que debemos analizar junto a la trayectoria laboral de esa misma persona. Para analizar conjuntamente las trayectorias laboral y de incapacidad disponemos de la Muestra Continua de Vidas Laborales de la Seguridad Social desde 2004. Una muestra de 873.008 afiliados (un 4%, aproximadamente) en 2009 entre los que se produjeron 163.136 episodios de incapacidad temporal (IT) iniciados en 2009, las cuales evolucionaron entre 2009 y 2012 a 4.738 casos de incapacidad permanente (IP). Un 2,9% en total, que fue del 12,6% en caso de tumores malignos (282 IP de 2.234 IT) y del 9,2% en el caso de enfermedades cardiovasculares (344 IP de 3.532 IT). En un contexto de incremento de la esperanza de vida y la prevalencia de enfermedades crónicas (vivimos más pero con más incapacidad) necesitamos analizar longitudinalmente las trayectorias de incapacidad para poder prevenir los años de vida laboral perdidos por IP, los cuales, como sabemos, están relacionados con la trayectoria laboral

No disponible

Emoción, contexto verbal y percepción de la expresión verbal: Dime quién eres y te diré cómo te percibo / Emotion, verbal context and facial expression perception: Tell me who you are and I will tell you how I perceive you

La percepción de la expresión facial en un contexto verbal facilita la activación del conocimiento conceptual a través del cual es interpretada. Con el objetivo de analizar cómo la emoción, a través del contexto verbal, modula la percepción de la expresión facial en sus niveles de valencia, activación y control, se realizó un primer experimento en el que se generó el contexto verbal mediante palabras de contenido emocional (positivo, negativo), antes del reconocimiento de una expresión mixta de alegría y tristeza. En un segundo experimento, manteniendo neutros tanto contexto verbal como expresión facial, se indujo un estado afectivo positivo o negativo, antes o después de la codificación del contexto verbal. En el primer experimento, la condición de contexto verbal positivo facilitó que la cara mixta de alegría se percibiera con una expresión de mayor seguridad/confianza (control) respecto a la cara mixta de tristeza. En el segundo experimento, la emoción positiva inducida de manera previa a la codificación del contexto verbal, generó que la cara se percibiera con una expresión de mayor activación, respecto a cuando la emoción fue negativa. Se discuten los resultados a partir del modelo constructivista de la emoción

Verbal context in the perception of facial expression facilitates the activation of conceptual knowledge through which is interpreted. With the aim of analyzing how emotion, via verbal context, modulates valence, arousal and control levels in the perception of facial expression, a first experiment was performed in which verbal context was generated using words with emotional content (positive, negative), prior to recognition of an expression mixed with happiness and sadness. In a second experiment, while maintaining both verbal and facial expression context neutral, a positive or negative affective state was induced either before or after the coding of verbal context. In the first experiment, the positive verbal context condition facilitated the face mixed with happiness to be perceived as an expression of greater security/trust (control) with respect to the face mixed with sadness. In the second experiment, the positive emotion induced prior to coding the verbal context produced the face to be perceived as having an expression of greater activation with respect to when the emotion was negative. The results are discussed from constructivist model of emotion

¿Es distinta la organización cerebral temprana de la información espacial transmitida a través de estímulos táctiles en niños invidentes congénitos y adquiridos?: un estudio piloto / Is the early brain organisation of spatial information conveyed by tactile stimuli performed in different ways in congenital and acquired blind children? A pilot study

La reorganización cortical subyacente a la ceguera congénita no se conoce suficientemente, pero esta última ofrece una ventana óptima para el estudio de los efectos de la deprivación sensorial absoluta. Se sabe también que existe cross-modality en el cerebro de los invidentes, pero ésta difiere en niños con ceguera congénita y aquellos otros con restos de visión. La estimulación vibrotáctil pasiva de líneas y letras genera patrones electroencefalográficos y de localización de fuentes distintos en dos niños de 9 y 10 años, respectivamente, con ceguera congénita y ceguera con restos de visión. En la niña con ceguera congénita, la mayor actividad eléctrica cortical se centra en áreas auditivas en P50 y P100, mientras que en el niño invidente con restos de visión, la actividad se distribuye en múltiples áreas. Los tiempos de reacción a las letras son menores que a las líneas de diferente orientación en ambos niños (AU)

Cortical reorganization after congenital blindness is not sufficiently known yet it does offer an optimum window of opportunity to study the effects of absolute sensorial deprivation. Cross-modality in people with blindness has been documented, but it may differ in congenital blindness and in early blindness. Vibrotactile passive stimulation of lines and letters generates different electroencephalographic patterns with different source localizations in two children with blindness, aged 9 and 10, respectively with congenital blindness and early blindness with some remnants of vision. Most of the brain electrical activity is centered in auditive areas in P50 and P100 in the case of the child with congenital blindness, while the other shows activity in multiple areas. Reaction times to letters are shorter than to lines of different orientation in both children (AU)